These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12682335)

  • 1. MRS in relation to hippocampal volume in the oldest old.
    Spencer DC; Zitzelberger T; Spielman D; Kaye J
    Neurology; 2003 Apr; 60(7):1194-6. PubMed ID: 12682335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
    Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
    Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior to posterior hippocampal MRS metabolite difference is mainly a partial volume effect.
    Starck G; Vkhoff-Baaz B; Ljungberg M; Malmgren K; Forssell-Aronsson E; Jönsson L; Ekholm S
    Acta Radiol; 2010 Apr; 51(3):351-9. PubMed ID: 20201639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Kramer J; Jagust W; Miller B; Wolkowitz OM; Yaffe K; Weiner MW
    Neurology; 2002 Mar; 58(6):928-35. PubMed ID: 11914410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of Braak stage- and APOE4 allele-dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly.
    Chen AM; Gajdošík M; Ahmed W; Ahn S; Babb JS; Blessing EM; Boutajangout A; de Leon MJ; Debure L; Gaggi N; Gajdošík M; George A; Ghuman M; Glodzik L; Harvey P; Juchem C; Marsh K; Peralta R; Rusinek H; Sheriff S; Vedvyas A; Wisniewski T; Zheng H; Osorio R; Kirov II
    Neuroimage; 2024 Aug; 297():120742. PubMed ID: 39029606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.
    Silveira de Souza A; de Oliveira-Souza R; Moll J; Tovar-Moll F; Andreiuolo PA; Bottino CM
    Dement Geriatr Cogn Disord; 2011; 32(5):351-61. PubMed ID: 22311276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus].
    Engelhardt E; Moreira DM; Laks J; Marinho VM; Rozenthal M; Oliveira AC
    Arq Neuropsiquiatr; 2001 Dec; 59(4):865-70. PubMed ID: 11733829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.
    Chao LL; Schuff N; Kramer JH; Du AT; Capizzano AA; O'Neill J; Wolkowitz OM; Jagust WJ; Chui HC; Miller BL; Yaffe K; Weiner MW
    Neurology; 2005 Jan; 64(2):282-9. PubMed ID: 15668426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE genotype modulates proton magnetic resonance spectroscopy metabolites in the aging brain.
    Gomar JJ; Gordon ML; Dickinson D; Kingsley PB; Uluğ AM; Keehlisen L; Huet S; Buthorn JJ; Koppel J; Christen E; Conejero-Goldberg C; Davies P; Goldberg TE
    Biol Psychiatry; 2014 May; 75(9):686-92. PubMed ID: 23831342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
    Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
    Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among hippocampal volumetry, proton magnetic resonance spectroscopy, and verbal memory in temporal lobe epilepsy.
    Sawrie SM; Martin RC; Knowlton R; Faught E; Gilliam F; Kuzniecky R
    Epilepsia; 2001 Nov; 42(11):1403-7. PubMed ID: 11879342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.
    Calderón-Garcidueñas L; Mora-Tiscareño A; Melo-Sánchez G; Rodríguez-Díaz J; Torres-Jardón R; Styner M; Mukherjee PS; Lin W; Jewells V
    J Alzheimers Dis; 2015; 48(4):1065-75. PubMed ID: 26402110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.